Business

AtkinsRéalis Bolsters Canada's Vaccine Manufacturing Capacity with Design of $109 Million Facility

AtkinsRéalis Bolsters Canada's Vaccine Manufacturing Capacity with Design of $109 Million Fa...

articleAtkinsrealis Group Inc.August 29, 20245/company/snc-lavalin-group-inc/news/atkinsrandxe9alis-bolsters-canadas-vaccine-manufacturing-capacity-with-design-of-dollar109-million-facility
AtkinsRéalis Bolsters Canada's Vaccine Manufacturing Capacity with Design of $109 Million Facility

About this update from Atkinsrealis Group Inc.

[{"type":"text","content":"\n\n\n\n AtkinsRéalis Bolsters Canada's Vaccine Manufacturing Capacity with Design of $109 Million Facility\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: TOP; TEXT-ALIGN: LEFT; BORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; BORDER-BOTTOM:black 0pt; BORDER-LEFT:black 0pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n MONTREAL\n \n\n ,\n \n\n Aug. 29, 2024\n \n\n /CNW/ - AtkinsRéalis Group Inc. (TSX: ATRL), a world-class engineering services and nuclear company with offices around the world, has won a mandate from Jubilant HollisterStier, a leading global pharmaceutical contract manufacturer, to provide detailed design for the expansion of their sterile injectable facility in\n \n Montreal\n \n as part of\n \n Canada's\n \n Biomanufacturing and Life Sciences Strategy pandemic preparedness plan to domestically manufacture and supply vaccines.\n \n\n\n\n\n\n\n\n\n \"Our life sciences and pharmaceutical capabilities are in demand and helping improve health outcomes in the communities we serve,\" commented\n \n Ian L. Edwards\n \n , President and Chief Executive Officer, AtkinsRéalis. \"We operationalize our purpose of engineering a better future for our planet and its people by working with clients in this space to ramp up their facilities to deliver cutting-edge medicine in a post-pandemic world. Having completed prior phases of work on this project for Jubilant HollisterStier, this new mandate is an endorsement of the quality of our service level, innovation, and expertise.\"\n \n\n AtkinsRéalis' Industrial team will provide an integrated end-to-end solution for this phase of the project, including design and professional engineering services for the facility and its manufacturing processes. Previous project mandates by AtkinsRéalis included concept design and preliminary engineering. The new spaces are expected to be operational by late 2026.\n \n\n\n Streng...

More updates from Atkinsrealis Group Inc.